Return to NG15 Overview

Antimicrobial stewardship: systems and processes for effective antimicrobial medicine use [NG15]

Measuring the use of this guidance

Recommendation: 1.1.38

Use an intravenous antimicrobial from the agreed local formulary and in line with local (where available) or national guidelines for a patient who needs an empirical intravenous antimicrobial for a suspected infection but has no confirmed diagnosis.

What was measured: Proportion of people with severe community-acquired pneumonia who commenced on antibiotics consistent with the study hospital’s antibiotic prescribing guidelines.
Data collection end: February 2017
70%
Number that met the criteria: 7 / 10
Area covered: Local
Source: Powell N, McGraw-Allen K, Menzies A, Peet B, Simmonds C, and Wild A. (2018). Identifying antibiotic stewardship interventions to meet the NHS England CQUIN: An evaluation of antibiotic prescribing against published evidence-based antibiotic audit tools. Clinical Medicine, and Journal of the Royal College of Physicians of London, 18(4), pp.276-281.


Recommendation: 1.1.39

Consider reviewing intravenous antimicrobial prescriptions at 48–72 hours in all health and care settings (including community and outpatient services). Include response to treatment and microbiological results in any review, to determine if the antimicrobial needs to be continued and, if so, whether it can be switched to an oral antimicrobial.

What was measured: Proportion of people with severe community-acquired pneumonia who were prescribed IV antibiotics whose prescription was reviewed within 72 hours.
Data collection end: February 2017
100%
Number that met the criteria: 10 / 10
Area covered: Local
Source: Powell N, McGraw-Allen K, Menzies A, Peet B, Simmonds C, and Wild A. (2018). Identifying antibiotic stewardship interventions to meet the NHS England CQUIN: An evaluation of antibiotic prescribing against published evidence-based antibiotic audit tools. Clinical Medicine, and Journal of the Royal College of Physicians of London, 18(4), pp.276-281.



 Return to NG15 Overview